Vara
Vara — Independent AI for Breast Screening
Vara develops CE-marked medical AI that supports radiologists and national screening programmes across Europe to detect breast cancer earlier and more reliably. Their technology integrates into existing workflows to provide fast, transparent, and configurable decision support so every read is more confident.
Our mission
We amplify human expertise by delivering clinically validated AI as an independent reader, safety net, and triage system. Vara’s products are designed to reduce radiologist workload, increase cancer detection, and provide continuous monitoring and evaluation tied to clinical outcomes.
Key facts
- CE-marked medical devices (EU MDR Class IIb) certified to operate as an independent reader.
- Clinically validated in the PRAIM study (460,000 participants) with results published in Nature Medicine.
- Deployed across over 50% of Germany’s national mammography screening programme and expanding across Europe.
- Core offerings: safety net, normal triaging, automated reporting, tomosynthesis (3D) support, and continuous monitoring.
- Designed for secure, GDPR-compliant deployments in regulated clinical environments.
